SHIKARI® Q-NIVO


Enzyme immunoassay for the quantitative determination of nivolumab (Opdivo®) in serum and plasma.

Enzyme immunoassay for the quantitative determination of nivolumab (Opdivo®) in serum and plasma. Matriks Biotek Nivolumab ELISA has been especially developed for the quantitative analysis of free nivolumab in serum and plasma samples at high specificity.



Click the diagram to see bigger



Required Volume (µl) 10
Total Time (min) 70
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) 10
Spike Recovery (%) Between 85-115
Shelf Life (year) 1

SHIKARI® S-ATN


Enzyme immunoassay for the qualitative determination (screening) of antibodies to nivolumab (Opdivo®) in serum and plasma.

The Matriks Biotek® Antibody to nivolumab (Opdivo®) Enzyme-Linked-ImmunoSorbentAssay (ELISA) Kit is intended for the qualitative determination of antibodies to nivolumab (Opdivo®) in serum and plasma.It is for professional use only.





Required Volume (µl) 10
Total Time (min) 140
Sample Serum, plasma
Sample Number 96
Detection Limit (ng/mL) + / -
Spike Recovery (%) -
Shelf Life (year) 1

MATRIKS BIOTECHNOLOGY CO., LTD

Gazi Üniversitesi Gölbaşı Yerleşkesi Teknoplaza Binası,
(B Blok Zemin Kat BZ17),
06830,
Gölbaşı/ANKARA/TÜRKİYE

Contact Details

Telephone: +90 (312) 485 42 94
Email: info@matriksbiotek.com
Fax: +90 (312) 485 11 87